Trial intelligence / Profile preview

Remimazolam versus propofol for blood pressure stability during anesthesia induction in elderly patients

jRCT1011230012Completed

Sponsor
Grants-in-Aid for Scientific Research from the Ministry of Education, Science, and Culture of Japan (22K10139)
Start
Jul 2023
Modality
Small Molecules
Countries
1
01

Overview

Randomised, single-blind trial of remimazolam and propofol (2 arms), sponsored by Grants-in-Aid for Scientific Research from the Ministry of Education, Science, and Culture of Japan (22K10139). Primary endpoint: Maximum change in mean blood pressure during general anesthesia induction. Started Jul 2023; status: completed.

02

Drugs

remimazolampropofol

Beyond the preview

Go deeper on jRCT1011230012.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on jRCT1011230012.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call